Ypsomed

0QLQ.L | LSE | 0 Followers
CHF 355.28 -0.06% -CHF 0.22
Follow
Overview Metrics Financials
Loading...

Fair Price

HUG 929.01
Overvalued by 31.1%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Ypsomed Holding AG is a Swiss technology company specializing in the development and manufacturing of drug delivery devices, primarily for diabetes and other chronic conditions. Founded in 2003, the company is now one of the leading global manufacturers of insulin pumps, injection pen systems, and other devices that make it easier for patients to manage and administer their treatment. Ypsomed focuses on innovations in biologic drug delivery and the development of new devices to improve patients' quality of life, such as automated insulin delivery systems. The company operates globally, with its products used in many countries.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade